/BP40087_paper_supplementary_code

Supplementary source code related to the clinical trial BP40087

Primary LanguageR

First-in-human study of the novel fibroblast activation protein-targeted 4-1BB agonist RO7122290 in patients with advanced solid tumors

Supplementary source code

Authors

  • Mariana Bustamante1
  • Eveline Nueesch1
  • Chiahuey Ooi1
  • Iakov I. Davydov1
  1. Roche Pharma Research and Early Development, Roche Innovation Center Basel; Basel, Switzerland

Would like to thank Nicolas Staedler who provided some of the codes used for analysis. We also would like to thank Alexandra-Cristina Nica who was involved in early stages of the analysis.